Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;6(1):1-6.
doi: 10.4103/0974-2727.129082.

Detection of AmpC β Lactamases in Gram-negative Bacteria

Affiliations

Detection of AmpC β Lactamases in Gram-negative Bacteria

Gunjan Gupta et al. J Lab Physicians. 2014 Jan.

Abstract

AmpC β-lactamases are clinically important cephalosporinases encoded on the chromosomes of many Enterobacteriaceae and a few other organisms, where they mediate resistance to cephalothin, cefazolin, cefoxitin, most penicillins, and β-lactamase inhibitor/β-lactam combinations. The increase in antibiotic resistance among Gram-negative bacteria is a notable example of how bacteria can procure, maintain and express new genetic information that can confer resistance to one or several antibiotics. Detection of organisms producing these enzymes can be difficult, because their presence does not always produce a resistant phenotype on conventional disc diffusion or automated susceptibility testing methods. These enzymes are often associated with potentially fatal laboratory reports of false susceptibility to β-lactams phenotypically. With the world-wide increase in the occurrence, types and rate of dissemination of these enzymes, their early detection is critical. AmpC β-lactamases show tremendous variation in geographic distribution. Thus, their accurate detection and characterization are important from epidemiological, clinical, laboratory, and infection control point of view. This document describes the methods for detection for AmpC β-lactamases, which can be adopted by routine diagnostic laboratories.

Keywords: AmpC β-lactamases; disk approximation test; gram-negative bacteria; three-dimensional extract test.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Representation of three dimensional extract test. (a) Zone of inhibition showing positive test, (b) no zone of inhibition showing negative test. *30 μg cefoxitin disk
Figure 2
Figure 2
Representation of AmpC disk test. (a) Zone of inhibition showing positive test results, (b) no zone of inhibition showing negative test results, *AmpC disks (filter paper containing tris-EDTA), CX: 30μg cefoxifin disks
Figure 3
Figure 3
Representation of boronic acid disk test. A: 30 μg cefoxitin disk supplemented with 300μg of phenyl boronic acid. B: 30 μg cofoxitin disk alone
Figure 4
Figure 4
Representation of disk approximation test. Flattening of zone of ceftazidime toward imipenem disk (inducing substrate) showing positive result. IMP: Imipenem (10 μg), CAZ: Ceftazidime (10 μg), AMC: Amoxillin-clavulanate (20/10 μg)

References

    1. Kaurthe J. Increasing antimicrobial resistance and narrowing therapeutics in typhoidal salmonellae. J Clin Diagn Res. 2013;7:576–9. - PMC - PubMed
    1. Laxminarayan R, Klugman KP. Communicating trends in resistance using a drug resistance index. BMJ Open. 2011;1:e000135. - PMC - PubMed
    1. Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23:160–201. - PMC - PubMed
    1. Hanson ND. AmpC beta-lactamases: What do we need to know for the future? J Antimicrob Chemother. 2003;52:2–4. - PubMed
    1. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40:2153–62. - PMC - PubMed

LinkOut - more resources